Compared with placebo , pitavastatin @ , @ , and @ mg significantly reduced LDL-C from baseline by @ % , @ % , and @ % , respectively , and in the open-label study @ % of the subjects reached the LDL-C goal < @ mg/dL ( @ mmol/L ) .